You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women

Article metrics

Article menu
XML
Dermatology
Protocol
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women

 

Online download statistics by month:

Online download statistics by month: August 2021 to October 2024

AbstractFullPdf
Aug 202125725322
Sep 202133132249
Oct 202121119937
Nov 202118016850
Dec 202115715320
Jan 202222620536
Feb 202213312621
Mar 202219118437
Apr 202218116958
May 202220320144
Jun 202223522341
Jul 202220520032
Aug 202225925239
Sep 202221721153
Oct 202222922955
Nov 202224322484
Dec 202215215019
Jan 202316415639
Feb 202315215238
Mar 202315915254
Apr 202315014637
May 202316515733
Jun 202316515732
Jul 2023918725
Aug 202313712944
Sep 202314513849
Oct 2023917926
Nov 202322019157
Dec 202314410132
Jan 202411210134
Feb 2024846628
Mar 202410910267
Apr 202411410660
May 2024857330
Jun 2024847747
Jul 202412811043
Aug 202410610552
Sep 202412010855
Oct 2024322816
Total636759901595